LMP Capital and Income Fund (SCD) offers a fairly diversified portfolio but is more uniquely positioned, with its largest allocations being to MLPs and technology sectors. The fund's discount has ...
LMP Capital and Income Fund has delivered strong performance, outperforming the benchmark and peer group. The fund's portfolio is well-positioned to navigate the current macroeconomic environment, ...
NICM: 6.10 appropriate treatments per 100 patient-years MI/CAD: 8.64 appropriate treatments per 100 patient-years The rate of appropriate LifeVest treatments in SCD-PROTECT was significantly higher ...
An engineered lentivirus was created to avoid some of the drawbacks associated with current gene therapy vectors for sickle cell disease (SCD) and beta-thalassemia. Researchers reported Friday that a ...
The question is, will it beat amiodarone in the nonischemic group? Prospective economic and quality-of-life analyses of SCD-HeFT data will be reported at a future meeting, Lee said. Of the patients in ...
81.7% of patients were on an SGLT2 inhibitor 74.7% of patients were on an ARNI 95.1% of patients were on a beta-blocker 83.1% of patients were on an MRA Despite high use of GDMT, the rate of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback